On May 29, 2024, Nukkleus Inc., a company listed on the Nasdaq Stock Market, received a notification from Nasdaq's Listing Qualifications Department for non-compliance with the exchange's Listing Rule 5250(c)(1). The non-compliance issue arose due to Nukkleus Inc.'s failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, in a timely manner. This notification is part of a series of warnings regarding the company's failure to meet certain listing requirements, including the Minimum Bid Price, Minimum Market Value of Publicly Held Shares, and Minimum Market Value of Listed Securities. Nukkleus Inc. has been given until July 29, 2024, to submit a compliance plan to Nasdaq and may receive an extension until November 11, 2024, to demonstrate compliance. The company is actively working to file the overdue Form 10-Q and regain compliance. Despite these notifications, the trading of Nukkleus Inc.'s common stock on the Nasdaq Global Market remains unaffected at this time.

On May 29, 2024, Nukkleus Inc., a company listed on the Nasdaq Stock Market, received a notification from Nasdaq's Listing Qualifications Department for non-compliance with the exchange's Listing Rule 5250(c)(1). The non-compliance issue arose due to Nukkleus Inc.'s failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, in a timely manner. This notification is part of a series of warnings regarding the company's failure to meet certain listing requirements, including the Minimum Bid Price, Minimum Market Value of Publicly Held Shares, and Minimum Market Value of Listed Securities. Nukkleus Inc. has been given until July 29, 2024, to submit a compliance plan to Nasdaq and may receive an extension until November 11, 2024, to demonstrate compliance. The company is actively working to file the overdue Form 10-Q and regain compliance. Despite these notifications, the trading of Nukkleus Inc.'s common stock on the Nasdaq Global Market remains unaffected at this time.